FDA Blocks Additional Versions of Generic Norvasc

Washington Drug Letter
KEYWORDS DrugApprovals / FDA
A A
FDA has barred all approvals for generic versions of Pfizer's Norvasc except for one issued earlier to Mylan, the agency announced in a notice to the U.S. District Court for the District of Columbia.

To View This Article:

Login